The applications of CRISPR technology are seemingly endless, with recent breakthroughs in xenotransplantation, sickle cell anemia, and crop resilience. In this article, we explore 7 unique applications driving this Nobel Prize-winning technology forward.
Ray speaks to Enara Nazarova, Founder at ARMOAR and a top 30 voice in the Metaverse. They discuss the digital direction of the creative industries and how the buying power of GenZ and young Millennials will impact these industries. Plus, they delve into how NFTs and composable tokens are just the beginning of the shift.
There are more than 454 million non-meat eaters in the world, and countless other consumers looking for meatless alternatives to improve their health, and the health of our planet. In this visual report, we walk you through how this industry is evolving and provide you with the insights needed to make informed decisions.
Ray speaks to Jonathan Hooker, investor and emerging technologies specialist about how next generation digital infrastructure is changing the game and the advancements in cryptocurrency and collaboration on Web3.
Technology scouting has become an essential part of the open innovation strategy, in which companies look externally for technical and market opportunities. In this article, we explore the benefits of this approach and highlight the innovative work of external scouting consultants, Strategic Allies.
Ray and Jens discuss the economic possibilities of a Web3 world, including how traditional finance institutions will have to adapt and the concept of 'tokenised equity'.
How can artificial intelligence enhance drug discovery, reduce cost, and bring new drugs to market faster? In this article we explore how AI is reshaping drug discovery as we know it.
Host Ray Chohan talks to entrepreneur and Web3 builder Sergej Lotz about his work on Web3, and the future trends, opportunities and challenges associated with NFTs, blockchain, and DAOs.
In our premiere episode of the Frontier3 podcast, we discuss the impact of Web3 and NFTs. Specifically, we look at how the web evolved from something we view to something we now control.
SPACs (Special Purpose Acquisition Companies) are regularly touted as the next frontier in going public, but what are the key risks and valuation challenges associated with this approach?
Many companies turn to University Technology Transfer Offices (TTOs) to facilitate research and move ideas to commercialization. Learn how to partner with University TTOs, and best practices to consider.
We’ve made updates to Innovation Academy, including introducing our new Academic in Residence program by IP expert and entrepreneur, Joe Sekhon. Here’s what you need to know.
Join PatSnap’s Senior Solutions Consultants, Elizabeth Holloway and Michelle Liu, and gain exclusive insight into how IoMT is Improving the patient experience, changing the treatment paradigm and transforming clinical trials.
Host Ray Chohan is joined by Steve Chiang, Vice President and Chief IP Counsel at RPX Corporation, to discuss patent licensing, the future of patent valuation, and more.